| Temperature treatment of highly porous zirconium-containing metal–organic frameworks extends drug delivery release MH Teplensky, M Fantham, P Li, TC Wang, JP Mehta, LJ Young, ... Journal of the American chemical society 139 (22), 7522-7532, 2017 | 331 | 2017 |
| Metal-organic frameworks as biosensors for luminescence-based detection and imaging SE Miller, MH Teplensky, PZ Moghadam, D Fairen-Jimenez Interface Focus 6 (4), 20160027, 2016 | 179 | 2016 |
| A highly porous metal-organic framework system to deliver payloads for gene knockdown MH Teplensky, M Fantham, C Poudel, C Hockings, M Lu, A Guna, ... Chem 5 (11), 2926-2941, 2019 | 90* | 2019 |
| Multi-antigen spherical nucleic acid cancer vaccines MH Teplensky, M Evangelopoulos, JW Dittmar, CM Forsyth, AJ Sinegra, ... Nature biomedical engineering 7 (7), 911-927, 2023 | 55 | 2023 |
| DNA dendrons as agents for intracellular delivery ME Distler, MH Teplensky, KE Bujold, CD Kusmierz, M Evangelopoulos, ... Journal of the American Chemical Society 143 (34), 13513-13518, 2021 | 41 | 2021 |
| Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets MH Teplensky, JW Dittmar, L Qin, S Wang, M Evangelopoulos, B Zhang, ... Advanced healthcare materials, e2101262, 2021 | 33 | 2021 |
| Spherical nucleic acids as an infectious disease vaccine platform MH Teplensky, ME Distler, CD Kusmierz, M Evangelopoulos, H Gula, ... Proceedings of the National Academy of Sciences 119 (14), e2119093119, 2022 | 31 | 2022 |
| Chemically tuning the antigen release kinetics from spherical nucleic acids maximizes immune stimulation K Skakuj, MH Teplensky, S Wang, JW Dittmar, CA Mirkin ACS central science 7 (11), 1838-1846, 2021 | 21 | 2021 |
| Molecular DNA dendron vaccines ME Distler, JP Cavaliere, MH Teplensky, M Evangelopoulos, CA Mirkin Proceedings of the National Academy of Sciences 120 (5), e2215091120, 2023 | 12 | 2023 |
| Modular nucleic acid scaffolds for synthesizing monodisperse and sequence-encoded antibody oligomers PH Winegar, CA Figg, MH Teplensky, N Ramani, CA Mirkin Chem 8 (11), 3018-3030, 2022 | 9 | 2022 |
| Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation JW Dittmar, MH Teplensky, M Evangelopoulos, L Qin, B Zhang, CA Mirkin ACS nano 17 (18), 17996-18007, 2023 | 7 | 2023 |
| Controlling intracellular machinery via polymer pen lithography molecular patterning M Lin, B Meckes, C Chen, MH Teplensky, CA Mirkin ACS Central Science 8 (9), 1282-1289, 2022 | 5 | 2022 |
| Harnessing biomaterial architecture to drive anticancer innate immunity MA Davis, E Cho, MH Teplensky Journal of Materials Chemistry B 11 (46), 10982-11005, 2023 | 1 | 2023 |
| Abstract A025: RNA-Based Therapeutics to target the p53 pathway in high-grade serous ovarian cancer: TAp63-Regulated Oncogenic LncRNAs (TROLLs) as novel therapeutic targets in … A Lui, M Napoli, JR Baldwin, CL Carr, A Rivera, D Nguyen, WG Sawyer, ... Molecular Cancer Therapeutics 23 (11_Supplement), A025-A025, 2024 | | 2024 |
| Abstract B011: RNA-based therapeutics to target the p53 pathway in cancer M Napoli, AK Lu, AA Deshpande, JR Baldwin, CL Carr, MR Dunne, ... Molecular Cancer Therapeutics 23 (11_Supplement), B011-B011, 2024 | | 2024 |
| RNA-Based Therapeutics to target the p53 pathway in high-grade serous ovarian cancer: TAp63-Regulated Oncogenic LncRNAs (TROLLs) as novel therapeutic targets in cancer A Lui, M Napoli, JR Baldwin, CL Carr, A Rivera, D Nguyen, WG Sawyer, ... MOLECULAR CANCER THERAPEUTICS 23 (11), 2024 | | 2024 |
| Drug and Gene Delivery III: Emerging Technologies D Samanta, A Brown, L Volpatti, M Teplensky 2024 AIChE Annual Meeting, 2024 | | 2024 |
| Drug and Gene Delivery II: Investigations towards Neuro & the Brain R Chattaraj, M Teplensky, L Volpatti 2024 AIChE Annual Meeting, 2024 | | 2024 |
| Drug and Gene Delivery: Vaccines and Immunotherapy M Teplensky, L Volpatti 2024 AIChE Annual Meeting, 2024 | | 2024 |
| Targeting multiple t cell types using spherical nucleic acid vaccine architecture CA Mirkin, MH Teplensky, M Evangelopoulos, S Wang US Patent App. 18/283,699, 2024 | | 2024 |
Marcus FanthamCurrent: ONI. Previous: University of Cambridge, University of OxfordCorreu electrònic verificat a oni.bio
